Karuna Therapeutics clinical trial pipeline

4 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 2 with minor changes only.

1. Notable

   Relapse Prevention Trial Evaluating KarXT Treatment in…Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

   Recruitment opened

   Karuna Therapeutics, Inc., a Bristol Myers Squibb company·Phase 3· NCT07686263· Registry history of NCT07686263 on ClinicalTrials.gov (opens the registry)

   Updated Sep 14, 2026

2. Notable

   KarXT With Administration of Antiemetics in Healthy Volunteers

   Recruitment opened

   Also in this update: Trial sites expanded: 0 → 4 locations

   Karuna Therapeutics, Inc., a Bristol Myers Squibb company·Phase 4· NCT07681076· Registry history of NCT07681076 on ClinicalTrials.gov (opens the registry)

   Updated Sep 18, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.